Supernus Pharmaceuticals SUPN Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's tax on share settlement?
- Supernus Pharmaceuticals (SUPN) reported tax on share settlement of $4.56M in Q1 2026.
- How has Supernus Pharmaceuticals's tax on share settlement changed year-over-year?
- Supernus Pharmaceuticals's tax on share settlement increased by 36.3% year-over-year, from $3.34M to $4.56M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.